From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis

por Bersanelli, Melissa, Buti, Sebastiano
Publicado 2017

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential

por Bersanelli, Melissa, Buti, Sebastiano
Publicado 2017

Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date

por Bersanelli, Melissa, Leonardi, Francesco, Buti, Sebastiano
Publicado 2018

Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review

por Mazzaschi, Giulia, Quaini, Federico, Buti, Sebastiano
Publicado 2022

Systemic adjuvant therapies in renal cell carcinoma

por Buti, Sebastiano, Bersanelli, Melissa, Donini, Maddalena, Ardizzoni, Andrea
Publicado 2012

Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report

por Bordi, Paola, Tiseo, Marcello, Baldari, Giorgio, Buti, Sebastiano
Publicado 2016

Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy

por Buti, Sebastiano, Leonetti, Alessandro, Dallatomasina, Alice, Bersanelli, Melissa
Publicado 2016

Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma

por Leonetti, Alessandro, Leonardi, Francesco, Bersanelli, Melissa, Buti, Sebastiano
Publicado 2017

Family history of cancer and DNA damage response genes: Two sides of the same coin?

por Cortellini, Alessio, Bersanelli, Melissa, Ficorella, Corrado, Buti, Sebastiano
Publicado 2018

Renal cell carcinoma and viral infections: A dangerous relationship?

por Bersanelli, Melissa, Casartelli, Chiara, Buti, Sebastiano, Porta, Camillo
Publicado 2022

Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials

por Bersanelli, Melissa, Petrelli, Fausto, Buti, Sebastiano, Stanganelli, Ignazio
Publicado 2021

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

por Facchinetti, Francesco, Bordi, Paola, Leonetti, Alessandro, Buti, Sebastiano, Tiseo, Marcello
Publicado 2018

Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review

por Bersanelli, Melissa, Brunelli, Matteo, Gnetti, Letizia, Maestroni, Umberto, Buti, Sebastiano
Publicado 2020

Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

por Buti, Sebastiano, Donini, Maddalena, Bersanelli, Melissa, Gattara, Alessia, Leonardi, Francesco, Passalacqua, Rodolfo
Publicado 2017

Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

por Buti, Sebastiano, Donini, Maddalena, Bersanelli, Melissa, Gattara, Alessia, Leonardi, Francesco, Passalacqua, Rodolfo
Publicado 2018

BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients

por Buti, Sebastiano, Trentini, Francesca, Sepe, Pierangela, Claps, Melanie, Isella, Luca, Verzoni, Elena, Procopio, Giuseppe
Publicado 2022

Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy

por Bersanelli, Melissa, Buti, Sebastiano, Camisa, Roberta, Brighenti, Matteo, Lazzarelli, Silvia, Mazza, Giancarlo, Passalacqua, Rodolfo
Publicado 2014

Differential diagnosis of COVID-19 at the chest computed tomography scan: A review with special focus on cancer patients

por Perrone, Fabiana, Balbi, Maurizio, Casartelli, Chiara, Buti, Sebastiano, Milanese, Gianluca, Sverzellati, Nicola, Bersanelli, Melissa
Publicado 2021

Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts

por Santini, Daniele, Banna, Giuseppe Luigi, Buti, Sebastiano, Isella, Luca, Stellato, Marco, Roberto, Michela, Iacovelli, Roberto
Publicado 2023

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

por Roviello, Giandomenico, Buti, Sebastiano, Cattrini, Carlo, Mennitto, Alessia, Messina, Carlo, Airoldi, Chiara, Vannini, Gianmarco, Bersanelli, Melissa
Publicado 2021